ReviewCurrent oncology (Toronto, Ont.)2022

Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer-A Literature Review.

Danilo Giffoni de Mello Morais Mata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.